Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma (Q44069647)

29 November 2017

Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma (English)

1 reference

29 November 2017

0 references

Tomizawa Y

1

1 reference

29 November 2017

Kohno T

2

1 reference

29 November 2017

Fujita T

3

1 reference

29 November 2017

Kiyama M

4

1 reference

29 November 2017

Saito R

5

1 reference

29 November 2017

Noguchi M

6

1 reference

29 November 2017

Matsuno Y

7

1 reference

29 November 2017

Hirohashi S

8

1 reference

29 November 2017

Yamaguchi N

9

1 reference

29 November 2017

Nakajima T

10

1 reference

29 November 2017

Yokota J

11

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

29 November 2017

1 reference

29 November 2017

18

1 reference

29 November 2017

4

1 reference

29 November 2017

1007-1014

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1202384

29 November 2017

0 references

cites work

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

p53 mutations in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

Comparative allelotype of early and advanced stage non-small cell lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

Pattern of p53 Gene Mutations in Breast Cancers of Women of the Midwestern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

p53: a frequent target for genetic abnormalities in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

Increased expression of mutant forms of p53 oncogene in primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

7 January 2021

Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

7 January 2021

High-throughput asymmetric-PCR SSCP analysis using well-controlled temperature conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

7 January 2021

p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

7 January 2021

Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202384

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1202384

1 reference

29 November 2017

1 reference